Biodesix (BDSX) Non-Current Debt (2019 - 2026)

Biodesix (BDSX) has reported Non-Current Debt for 8 consecutive years, with $46.5 million the latest figure, recorded in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $46.5 million, up 26.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.5 million (up 26.69% YoY), and the FY2025 annual result was $47.4 million, up 30.31% from the prior year.
• Non-Current Debt was $46.5 million for Q1 2026 at Biodesix, down from $47.4 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $47.4 million in Q4 2025 and troughed at $4.9 million in Q3 2022.
• Average Non-Current Debt over 5 years is $31.0 million, with a median of $35.5 million recorded in 2024.
• Year-over-year, Non-Current Debt slumped 83.72% in 2022 and soared 411.27% in 2023.
• Over 5 years, Non-Current Debt stood at $25.0 million in 2022, then jumped by 40.88% to $35.2 million in 2023, then advanced by 3.36% to $36.4 million in 2024, then soared by 30.31% to $47.4 million in 2025, then dropped by 2.02% to $46.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $46.5 million in Q1 2026, $47.4 million in Q4 2025, and $47.1 million in Q3 2025.